169 related articles for article (PubMed ID: 17599443)
1. Relation of PCSK9 mutations to serum low-density lipoprotein cholesterol in childhood and adulthood (from The Bogalusa Heart Study).
Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
Am J Cardiol; 2007 Jul; 100(1):69-72. PubMed ID: 17599443
[TBL] [Abstract][Full Text] [Related]
2. The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population.
Hooper AJ; Marais AD; Tanyanyiwa DM; Burnett JR
Atherosclerosis; 2007 Aug; 193(2):445-8. PubMed ID: 16989838
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal association of PCSK9 sequence variations with low-density lipoprotein cholesterol levels: the Coronary Artery Risk Development in Young Adults Study.
Huang CC; Fornage M; Lloyd-Jones DM; Wei GS; Boerwinkle E; Liu K
Circ Cardiovasc Genet; 2009 Aug; 2(4):354-61. PubMed ID: 20031607
[TBL] [Abstract][Full Text] [Related]
4. Ethnic differences in the frequency of the cardioprotective C679X PCSK9 mutation in a West African population.
Sirois F; Gbeha E; Sanni A; Chretien M; Labuda D; Mbikay M
Genet Test; 2008 Sep; 12(3):377-80. PubMed ID: 18652535
[TBL] [Abstract][Full Text] [Related]
5. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
Cohen JC; Boerwinkle E; Mosley TH; Hobbs HH
N Engl J Med; 2006 Mar; 354(12):1264-72. PubMed ID: 16554528
[TBL] [Abstract][Full Text] [Related]
6. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.
Cohen J; Pertsemlidis A; Kotowski IK; Graham R; Garcia CK; Hobbs HH
Nat Genet; 2005 Feb; 37(2):161-5. PubMed ID: 15654334
[TBL] [Abstract][Full Text] [Related]
7. A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol.
Fasano T; Cefalù AB; Di Leo E; Noto D; Pollaccia D; Bocchi L; Valenti V; Bonardi R; Guardamagna O; Averna M; Tarugi P
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):677-81. PubMed ID: 17170371
[TBL] [Abstract][Full Text] [Related]
8. Effects of PCSK9 genetic variants on plasma LDL cholesterol levels and risk of premature myocardial infarction in the Italian population.
Guella I; Asselta R; Ardissino D; Merlini PA; Peyvandi F; Kathiresan S; Mannucci PM; Tubaro M; Duga S
J Lipid Res; 2010 Nov; 51(11):3342-9. PubMed ID: 20699424
[TBL] [Abstract][Full Text] [Related]
9.
Kent ST; Rosenson RS; Avery CL; Chen YI; Correa A; Cummings SR; Cupples LA; Cushman M; Evans DS; Gudnason V; Harris TB; Howard G; Irvin MR; Judd SE; Jukema JW; Lange L; Levitan EB; Li X; Liu Y; Post WS; Postmus I; Psaty BM; Rotter JI; Safford MM; Sitlani CM; Smith AV; Stewart JD; Trompet S; Sun F; Vasan RS; Woolley JM; Whitsel EA; Wiggins KL; Wilson JG; Muntner P
Circ Cardiovasc Genet; 2017 Aug; 10(4):e001632. PubMed ID: 28768753
[TBL] [Abstract][Full Text] [Related]
10. Both rare and common variants in PCSK9 influence plasma low-density lipoprotein cholesterol level in American Indians.
Tsai CW; North KE; Tin A; Haack K; Franceschini N; Saroja Voruganti V; Laston S; Zhang Y; Best LG; MacCluer JW; Beaty TH; Navas-Acien A; Kao WH; Howard BV
J Clin Endocrinol Metab; 2015 Feb; 100(2):E345-9. PubMed ID: 25412415
[TBL] [Abstract][Full Text] [Related]
11. Molecular population genetics of PCSK9: a signature of recent positive selection.
Ding K; Kullo IJ
Pharmacogenet Genomics; 2008 Mar; 18(3):169-79. PubMed ID: 18300938
[TBL] [Abstract][Full Text] [Related]
12. PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: a cross-sectional cohort study.
Saavedra YG; Dufour R; Davignon J; Baass A
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2700-5. PubMed ID: 25278291
[TBL] [Abstract][Full Text] [Related]
13. A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol.
Kotowski IK; Pertsemlidis A; Luke A; Cooper RS; Vega GL; Cohen JC; Hobbs HH
Am J Hum Genet; 2006 Mar; 78(3):410-22. PubMed ID: 16465619
[TBL] [Abstract][Full Text] [Related]
14. The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. men.
Scartezini M; Hubbart C; Whittall RA; Cooper JA; Neil AH; Humphries SE
Clin Sci (Lond); 2007 Dec; 113(11):435-41. PubMed ID: 17550346
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly population.
Polisecki E; Peter I; Robertson M; McMahon AD; Ford I; Packard C; Shepherd J; Jukema JW; Blauw GJ; Westendorp RG; de Craen AJ; Trompet S; Buckley BM; Murphy MB; Ordovas JM; Schaefer EJ;
Atherosclerosis; 2008 Sep; 200(1):95-101. PubMed ID: 18262190
[TBL] [Abstract][Full Text] [Related]
16. PCSK9 gene mutations and low-density lipoprotein cholesterol.
Wu NQ; Li JJ
Clin Chim Acta; 2014 Apr; 431():148-53. PubMed ID: 24518357
[TBL] [Abstract][Full Text] [Related]
17. PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses.
Benn M; Nordestgaard BG; Grande P; Schnohr P; Tybjaerg-Hansen A
J Am Coll Cardiol; 2010 Jun; 55(25):2833-42. PubMed ID: 20579540
[TBL] [Abstract][Full Text] [Related]
18. Sequence variation in proprotein convertase subtilisin/kexin type 9 serine protease gene, low LDL cholesterol, and cancer incidence.
Folsom AR; Peacock JM; Boerwinkle E
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2455-8. PubMed ID: 18006936
[TBL] [Abstract][Full Text] [Related]
19. Molecular biology of PCSK9: its role in LDL metabolism.
Horton JD; Cohen JC; Hobbs HH
Trends Biochem Sci; 2007 Feb; 32(2):71-7. PubMed ID: 17215125
[TBL] [Abstract][Full Text] [Related]
20. Biomedicine. Lowering LDL--not only how low, but how long?
Brown MS; Goldstein JL
Science; 2006 Mar; 311(5768):1721-3. PubMed ID: 16556829
[No Abstract] [Full Text] [Related]
[Next] [New Search]
